Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-dwq4g Total loading time: 0 Render date: 2024-07-26T10:28:14.910Z Has data issue: false hasContentIssue false

Vigabatrin

Published online by Cambridge University Press:  04 August 2010

Philip N. Patsalos
Affiliation:
Chalfont Centre for Epilepsy, Buckinghamshire, UK
Blaise F. D. Bourgeois
Affiliation:
Harvard Medical School, Boston
Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Conway, M, Cubbidge, RP, Hoskings, SL. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy. Epilepsia 2008; 49: 108–116.CrossRefGoogle ScholarPubMed
Johannessen, Landmark C, Patsalos, PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotherapeutics 2010; 10: 119–140.CrossRefGoogle Scholar
Patsalos, PN. Anti-epileptic drug interactions. A clinical guide. Clarius Press: Guildford, UK; 2005.Google Scholar
Patsalos, PN, Duncan, JS. The pharmacology and pharmacokinetics of vigabatrin. Reviews in Contemporary Pharmacotherapy 1995; 6: 447–456.
Ryan, MF, Samy, A, Young, J. Vigabatrin causes profound reduction in serum alanine transferase activity. Annals of Clinical Biochemistry 1996; 33: 257–258.CrossRefGoogle Scholar
Shields, WD. Infantile spasms: little seizures, big consequences. Epilepsy Currents 2006; 6: 63–69.CrossRefGoogle Scholar
Sills, GJ, Patsalos, PN, Butler, E, Forrest, G, Ratnaraj, N, Brodie, MJ. Visual field constrictions. Accumulation of vigabatrin but not tiagabine in the retina. Neurology 2001; 57: 196–200.CrossRefGoogle Scholar
Wheles, JW, Clarke, DF, Arzimanoglou, A, Carpenter, D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disorders 2007; 9: 353–412.Google Scholar
Wheles, JW, Ramsey, RE, Collins, SD. Vigabatrin. Neurotherapeutics 2007; 4: 163–172.CrossRefGoogle Scholar
Willmore, LJ, Abelson, MB, Ben-Menachem, E, Pellock, JM, Shields, WD. Vigabatrin: 2008 update. Epilepsia 2009; 50: 163–173.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×